## Abstract The molecular basis for the pharmacologic effects of __N__β(4βhydroxyphenyl)retinamide (4HPR) was investigated by studying the gene(s) that this compound may upregulate in cultured human epithelial tumor cells. Treatment of the cultured human nasopharyngeal carcinomaβderived cells (CNE3
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines
β Scribed by Changping Zou; Yongli Guan; Changchun Zou; Jian Wang; Li-E. Wang; Monica Liebert; H.Barton Grossman; Qingyi Wei
- Book ID
- 117467257
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 160 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The synthetic retinoid fenretinide [Nβ(4βhydroxyphenyl)retinamide, 4βHPR] has demonstrated growth inhibition and induction of apoptosis of various malignant cells, including lung cancer cell lines. 4βHPR is now being investigated in several clinical trials. In our study, we show that 4β
## Abstract __N__β(4βhydroxyphenyl)retinamide (4HPR, fenretinide), a retinoic acid (RA) derivative and a potential cancer preventive agent, is known to exert its chemotherapeutic effects in cancer cells through induction of apoptosis. Earlier work from our laboratory has shown that relatively low c